Skinbiotherapeutics (SBTX)

Company name:	Skinbiotherapeutics Plc
Company Description:	SkinBioTherapeutics is a life science company focused on skin health.
EPIC:	SBTX	Trading Currency:	GBX
Market Sector:	AMQ1	ISIN:	GB00BF33H870
Market Segment:	ASQ1	Share Type:	DE
WWW Address:	http://www.skinbiotherapeutics.com/	Description:	ORD 1P
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Skinbiotherapeutics Key Figures

(at previous day's close)
Market Cap.	99.77	m
Shares In Issue	155.89	m
Prev. Close	64.00
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-1.17	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-0.57	p
Return On Equity (ROE)	-60.83	%
Operating Margin	-	%
PEG Factor	-
EPS Growth Rate	-24.47	%
Dividends PS Growth Rate	-	%
Net Debt	-1.85	m
Gross Gearing	11.00	%
Quick Assets	2.35	m
Net Working Capital	2.04	m
Intangibles / Fixed Assets	99.60	%
Turnover PS	-	p
Pre-Tax Profit PS	-1.04	p
Retained Profit PS	-0.10	p
Cash PS	1.38	p
Net Cash PS	1.19	p
Net Tangible Asset Value PS *	1.31	p
Net Asset Value PS	1.58	p
Spread	2.00 (3.08%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	64.30	-0.30	-0.47	61.50	0.39		63.83
4 weeks	63.00	1.00	1.59	58.00	0.69		64.44
12 weeks	41.00	23.00	56.10	36.00	1.08		51.70
26 weeks	15.25	48.75	319.67	7.58	1.23		39.28
1 year	17.88	46.13	258.04	7.58	0.93		31.82
3 years	16.25	47.75	293.85	5.75	0.56		25.06
5 years	13.25	50.75	383.02	5.75	0.50		22.60
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	29.77
Tobin's Q Ratio (excl. intangibles)	33.62
Dividend Yield	-	%
Market-to-Book Ratio	40.46
Price-to-Pre-Tax Profit PS	-61.58
Price-to-Retained Profit PS	-664.75
Price-to-Cash Flow PS	-111.83
Price-to-Sales PS	-
Price-to-Net Tangible Asset Value PS	48.78
Price-to-Cash PS	46.21
Net Working Capital PS	1.31
Price Pct to Working Capital PS	48.82	%
Earnings Yield	-	%
Average PE	-
Years in average	-
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	-	%
Debt-to-Equity Ratio	-
Debt-to-Equity Ratio (excl. Intgbl)	-
Debt-to-Equity Market Value	-
Net Gearing	-66.92	%
Net Gearing (excl. Intangibles)	-78.90	%
Gross Gearing	11.00	%
Gross Gearing (excl. Intangibles)	12.97	%
Gearing Under 1 Year	11.00	%
Gearing Under 1 Year (excl. Intgbl)	12.97	%
Assets/Equity	1.12
Cash/Equity	87.56
(Liquidity Ratios)
Net Working Capital to Total Assets	73.76	%
Current Ratio	7.70
Quick Ratio (Acid Test)	7.70
Liquidity Ratio	7.08
Cash & Equiv/Current Assets	91.94	%
(Solvency Ratios)
Enterprise Value	97.61	m
CFO/Sales	-
CFO/Attributable Profit	-
CFO/Assets	-0.32
CFO/Debt	-2.93
Total Debt/Equity Market Value	0.00
Total Debt/Sales	-
Total Debt/Pre-Tax Profit	-0.19
Total Debt	0.30	m
Total Debt/Net Current Assets	0.15	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	2

Beta (60-Mnth)	Beta (36-Mnth)
-0.0017	0.0040

(Profitability Ratios)
Return On Capital Employed (ROCE)	-65.70	%
Return On Assets (ROA)	-44.76	%
Net Profit Margin	-	%
Assets Turnover	-
Return On Equity (ROE)	-60.83	%
Return On Investment (ROI)	-47.80	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	-
Fixed Assets Turnover	-
Current Assets Turnover	-
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	-
Debtors-to-Sales	-	%
Debt Collection Period	-	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.